Status:

RECRUITING

The Role of 18F-FDG&68Ga-FAPI PET/CT in the Assessment of Conversion Therapy Efficacy in Gastric Cancer with Peritoneal Metastasis.

Lead Sponsor:

Ruijin Hospital

Conditions:

Peritoneal Metastasis

Gastric Cancer

Eligibility:

All Genders

18+ years

Brief Summary

This study aims to investigate the value of 18F-FDG\&68Ga-FAPI PET/CT in evaluating the outcome of conversion therapy and the prognosis of people with peritoneal metastases from gastric cancer.

Detailed Description

If the target population of the study agrees to participate in the study, we will number the participants, resume their pathology files, and collect their gender, age, phone number, height and weight ...

Eligibility Criteria

Inclusion

  • Histologically confirmed gastric adenocarcinoma with no history of resection of primary or metastatic lesions
  • Peritoneal metastases of gastric cancer requiring laparoscopy for definitive diagnosis without gastric outflow tract obstruction and intestinal obstruction
  • Patients voluntarily enrolled in this study by signing an informed consent form
  • Age ≥ 18 years
  • Eastern Cooperative Oncology Group (ECOG) score ≤ 2,
  • Expected life expectancy ≥ 3 months
  • Adequate organ and bone marrow function
  • Willingness to adhere to the study protocol and follow-up programme

Exclusion

  • Signs of distant metastases other than peritoneal metastases at enrolment
  • Pregnant or breastfeeding women.
  • Patients with a history of other malignant diseases in the last 5 years, except cured skin cancer and carcinoma in situ of cervix
  • Severe mental disease, uncontrolled epilepsy, or central nervous system disease

Key Trial Info

Start Date :

June 15 2024

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

May 31 2029

Estimated Enrollment :

30 Patients enrolled

Trial Details

Trial ID

NCT06597526

Start Date

June 15 2024

End Date

May 31 2029

Last Update

September 19 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Ruijin Hospital affiliated to Shanghai Jiao Tong University of Medicine

Shanghai, Shanghai Municipality, China, 200025